NDC 0641-6166-01 - Amikacin Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6166
- Requested NDC
- 0641-6166-01
- Package NDCs from labels
- 0641-6166-01, 0641-6166-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMIKACIN SULFATE INJECTION, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6166-01 | Amikacin Sulfate | 4 mL in 1 VIAL | INJECTION | 4 | 10 | |
| 0641-6166-10 | Amikacin Sulfate | 10 in 1 CARTON | INJECTION | 10 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6166-01 | ML - Milliliter | 0641-6166 | 3cfe97bf-23bc-48b5-82f2-8afece928a16 | 1 | 2016-01-13 |
| 0641-6166-10 | ML - Milliliter | 0641-6166 | 3b98a712-a6ff-48bd-bc4f-95d6ae0cc65a | 1 | 2016-01-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMIKACIN SULFATE | ACTIVE INGREDIENT | N6M33094FD | AMIKACIN SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| AMIKACIN | ACTIVE MOIETY | 84319SGC3C | AMIKACIN SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| SODIUM CITRATE, UNSPECIFIED FORM | INACTIVE INGREDIENT | 1Q73Q2JULR | AMIKACIN SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| SODIUM METABISULFITE | INACTIVE INGREDIENT | 4VON5FNS3C | AMIKACIN SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | AMIKACIN SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | AMIKACIN SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Eye Wash | WATER | Chain Drug Marketing Assoc., Inc. | 1fb8a109-351b-7039-e063-6394a90a7311 | 2025-12-30 | Warnings | 059QF0KO0R |
| Rite Aid Eye Wash | PURIFIED WATER | Rite Aid | 28a18e04-d735-a511-e063-6394a90af6bb | 2025-12-30 | Warnings | 059QF0KO0R |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | 059QF0KO0R |
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Sterile Cord Blood Collection Unit (MSC128D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 251fd4cb-4aa4-4473-9f89-968da856eb77 | 2025-12-18 | Warnings | 1Q73Q2JULR |
| Sterile Cord Blood Collection Unit (MSC127D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 75a008b2-9666-4bfa-ab18-6d09b43b2215 | 2025-12-18 | Warnings | 1Q73Q2JULR |
| Pall Sterile Cord Blood Collection Unit | STERILE CORD BLOOD COLLECTION UNIT | Global Life Sciences Solutions USA LLC | aa9340b7-cc63-e17d-e053-2a95a90ad4d9 | 2025-12-18 | Warnings | 1Q73Q2JULR |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| OP-P | EMOTIONAL HEALTH BOOSTER | Vitality Works, Inc. | a8b87a49-fc73-4494-8dc9-059bc5f82d42 | 2025-12-17 | Warnings | O40UQP6WCF |
| Slenderiix | WEIGHT MANAGEMENT FORMULA | Vitality Works | 398251ec-6834-4dda-abc6-f503632d1632 | 2025-12-17 | Warnings | O40UQP6WCF |
| STERILE CORD BLOOD COLLECTION UNIT (MSC123D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE | Maco Productions | e3b456ec-4578-485f-a696-8a343505f30b | 2025-12-16 | Warnings | 1Q73Q2JULR |
| Amikacin Sulfate | AMIKACIN SULFATE | Qilu Pharmaceutical Co., Ltd. | 20fa61ef-11e2-4d01-82ea-b5412cefaead | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 1723156 1723160 N6M33094FD |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| PaxLyte | LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULE | Jaymac Pharmaceuticals | f520b130-61b3-443e-aaf6-91e094e7a334 | 2025-12-08 | Warnings, Adverse reactions | 1Q73Q2JULR |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | 1Q73Q2JULR | |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.